Cue Biopharma reports Q2 EPS (20c), consensus (25c)
PremiumThe FlyCue Biopharma reports Q2 EPS (20c), consensus (25c)
2M ago
Options Volatility and Implied Earnings Moves Today, August 19, 2024
Premium
Market News
Options Volatility and Implied Earnings Moves Today, August 19, 2024
2M ago
Cue Biopharma price target lowered to $3 from $8 at Piper Sandler
Premium
The Fly
Cue Biopharma price target lowered to $3 from $8 at Piper Sandler
2M ago
Cue Biopharma Welcomes Michael J. Fox to Board, Shareholders Vote
PremiumCompany AnnouncementsCue Biopharma Welcomes Michael J. Fox to Board, Shareholders Vote
4M ago
Cue Biopharma presents updated data from Phase 1 trial of CUE-101
Premium
The Fly
Cue Biopharma presents updated data from Phase 1 trial of CUE-101
4M ago
Cue Biopharma reports Q1 EPS (25c), consensus (28c)
Premium
The Fly
Cue Biopharma reports Q1 EPS (25c), consensus (28c)
5M ago
Cue Biopharma initiated with a Buy at Jefferies
PremiumThe FlyCue Biopharma initiated with a Buy at Jefferies
7M ago
Cue Biopharma presenting data on lead clinical asset CUE-101 at symposium
Premium
The Fly
Cue Biopharma presenting data on lead clinical asset CUE-101 at symposium
7M ago
Cue Biopharma reports Q3 EPS (24c), consensus (34c)
Premium
The Fly
Cue Biopharma reports Q3 EPS (24c), consensus (34c)
11M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100